Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > Another unjustified day down and another buy rating
View:
Post by Stockcoach1 on Oct 13, 2015 6:15pm

Another unjustified day down and another buy rating

https://www.bloomburton.com/research/CXRX20151012.pdf
Comment by healthstock1234 on Oct 13, 2015 6:27pm
Will Dems crush biotech tonight? https://video.cnbc.com/gallery/?video=3000431742 S&P/TSX, DOW,NASDAQ were down today.
Comment by TheRock07 on Oct 13, 2015 6:55pm
Gimme a break. Most of the great drug discoveries are made and tested in the US. Thats why prices are high. There is no way Clinton and the Dems are going to overcome the disasters of the Obama years. They will be swept in the next elections. Concordia is a screaming buy. Value cannot be suppressed for long..
Comment by simmer1965 on Oct 13, 2015 8:58pm
Most of the great drug discoveries....you must be a Dr.  What great drug discoveries????  Viagra?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities